1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with gadolinium chloride in 2 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (gadolinium chloride) | Trials (gadolinium chloride) | Recent Studies (post-2010) (gadolinium chloride) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 567 | 1 | 116 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Levine, BA; McCollum, MO; Olson, MS; Zhou, W | 1 |
Bartha, K; Jenei, B; Lázár, G; Medgyesi, GA | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and gadolinium chloride
Article | Year |
---|---|
Inflammation and platelet-activating factor production during hepatic ischemia/reperfusion.
Topics: Alanine Transaminase; Allopurinol; Animals; Azepines; Gadolinium; Hepatitis; Ischemia; Leukocytes; Liver; Male; Necrosis; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Triazoles | 1992 |
Hypotensive action of IgG preparations containing aggregates is suppressed by PAF-receptor antagonist BN 52021 and by gadolinium chloride (an agent blocking Kupffer cell function).
Topics: Animals; Captopril; Diterpenes; Female; Gadolinium; Ginkgolides; Hypotension; Immunoglobulin G; Kupffer Cells; Lactones; Macromolecular Substances; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1991 |